First AD

Second AD

Ophthalmology

GEN-22-MDD0531 - /clinical/ophthalmology

Ophthalmology page, resources on the topics of medical news and expert insight into ophthalmic disease can be found. Content includes articles, interviews, videos, podcasts, and breaking news on eye disease research, treatment, and drug development.

Age-Related Macular Degeneration

age-related macular degeneration condition center page is a comprehensive resource for clinical news and insights on retina disease. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for patients with AMD.

Diabetic Macular Edema

The HCPLive diabetic macular edema page is a comprehensive resource for clinical news and insights on DME. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for the leading cause of blindness, and more.

Optimizing Anti-VEGF Treatment Outcomes in Neovascular AMD and DME

HCPLive® Peer Exchange panel discussions feature authoritative insights, opinions, and perspectives on important issues facing today's care professionals.

Peer Exchange

Experts discuss emerging gene therapies for age-related macular degeneration (AMD) or diabetic macular edema (DME) and key end points considerations. 

Emerging Gene Therapies for Retinal Diseases

Overview of Anti-VEGF Treatments for AMD and DME

Barriers to Optimal Treatment Outcomes

Patient and Cross-Care Education Strategies for AMD and DME 

Real-World Long-Term Safety Data of Anti-VEGF Agents

Treat and Extend Strategy for Anti-VEGF Injections

Markers of Disease Progression in nAMD Patients 

Significance of SRF vs IRF in nAMD

Current Treatment Options for nAMD

Managing Suboptimal Responders to Anti-VEGF Treatment

Applying CATT Study Results in Real World

Long-Term Treatment Experience with Aflibercept

Treat and Extend Strategy for Aflibercept

Prospective Therapies and Treatment Strategies for nAMD

Unique Challenges of DME Treatment

Key Findings of Protocol T Study

Key Findings of DRCR Protocol AC Study

Step Therapy for Patients With DME

Efficacy of Faricimab in Clinical Trails

High Dose Aflibercept as Emerging Therapy for Retinal Diseases

Other Emerging Retinal Disease Therapies 

Final Thoughts on Retinal Disease Treatments and Outcomes